Concentrix Corporation
CNXC · NASDAQ
11/30/2024 | 11/30/2023 | 11/30/2022 | 11/30/2021 | |
|---|---|---|---|---|
| Revenue | $9,619 | $7,115 | $6,324 | $5,587 |
| % Growth | 35.2% | 12.5% | 13.2% | – |
| Cost of Goods Sold | $6,170 | $4,537 | $4,067 | $3,618 |
| Gross Profit | $3,449 | $2,578 | $2,257 | $1,969 |
| % Margin | 35.9% | 36.2% | 35.7% | 35.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2,853 | $1,917 | $1,617 | $1,397 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2,853 | $1,917 | $1,617 | $1,397 |
| Operating Income | $596 | $661 | $640 | $572 |
| % Margin | 6.2% | 9.3% | 10.1% | 10.2% |
| Other Income/Exp. Net | -$297 | -$253 | -$35 | -$17 |
| Pre-Tax Income | $299 | $408 | $605 | $556 |
| Tax Expense | $48 | $94 | $169 | $150 |
| Net Income | $251 | $314 | $435 | $406 |
| % Margin | 2.6% | 4.4% | 6.9% | 7.3% |
| EPS | 3.72 | 5.72 | 8.34 | 7.78 |
| % Growth | -35% | -31.4% | 7.2% | – |
| EPS Diluted | 3.71 | 5.7 | 8.28 | 7.7 |
| Weighted Avg Shares Out | 65 | 54 | 51 | 51 |
| Weighted Avg Shares Out Dil | 65 | 54 | 52 | 52 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $322 | $201 | $70 | $23 |
| Depreciation & Amortization | $706 | $388 | $310 | $277 |
| EBITDA | $1,327 | $998 | $985 | $856 |
| % Margin | 13.8% | 14% | 15.6% | 15.3% |